Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-20474
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHolper, Lisa-
dc.contributor.authorHengartner, Michael Pascal-
dc.date.accessioned2020-09-10T17:18:28Z-
dc.date.available2020-09-10T17:18:28Z-
dc.date.issued2020-
dc.identifier.issn1471-244Xde_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/20474-
dc.description.abstractThe issue of unblinded outcome-assessors and patients has repeatedly been stressed as a flaw in allegedly double-blind antidepressant trials. Unblinding bias can for example result from a drug's marked side effects. If such unblinding bias is present for a given drug, then it might be expected that the placebos of that drug are rated significantly less effective than that of other antidepressants.de_CH
dc.language.isoende_CH
dc.publisherBioMed Centralde_CH
dc.relation.ispartofBMC Psychiatryde_CH
dc.rightshttps://creativecommons.org/licenses/by/4.0/de_CH
dc.subjectAntidepressantsde_CH
dc.subjectBayesian network meta-analysisde_CH
dc.subjectPlacebode_CH
dc.subjectSide-effectsde_CH
dc.subjectUnblindingde_CH
dc.subject.ddc615: Pharmakologie und Therapeutikde_CH
dc.subject.ddc616.8: Neurologie und Krankheiten des Nervensystemsde_CH
dc.titleComparative efficacy of placebos in short-term antidepressant trials for major depression : a secondary meta-analysis of placebo-controlled trialsde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementAngewandte Psychologiede_CH
zhaw.organisationalunitPsychologisches Institut (PI)de_CH
dc.identifier.doi10.1186/s12888-020-02839-yde_CH
dc.identifier.doi10.21256/zhaw-20474-
dc.identifier.pmid32894088de_CH
zhaw.funding.euNode_CH
zhaw.issue1de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.start437de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume20de_CH
zhaw.publication.reviewOpen peer reviewde_CH
zhaw.webfeedKlinische Psychologiede_CH
zhaw.author.additionalNode_CH
zhaw.display.portraitYesde_CH
Appears in collections:Publikationen Angewandte Psychologie

Files in This Item:
File Description SizeFormat 
2020_Hopler_Comparative_efficacy_of_placebos_BMC_Psychiatry.pdf1.1 MBAdobe PDFThumbnail
View/Open
Show simple item record
Holper, L., & Hengartner, M. P. (2020). Comparative efficacy of placebos in short-term antidepressant trials for major depression : a secondary meta-analysis of placebo-controlled trials. BMC Psychiatry, 20(1), 437. https://doi.org/10.1186/s12888-020-02839-y
Holper, L. and Hengartner, M.P. (2020) ‘Comparative efficacy of placebos in short-term antidepressant trials for major depression : a secondary meta-analysis of placebo-controlled trials’, BMC Psychiatry, 20(1), p. 437. Available at: https://doi.org/10.1186/s12888-020-02839-y.
L. Holper and M. P. Hengartner, “Comparative efficacy of placebos in short-term antidepressant trials for major depression : a secondary meta-analysis of placebo-controlled trials,” BMC Psychiatry, vol. 20, no. 1, p. 437, 2020, doi: 10.1186/s12888-020-02839-y.
HOLPER, Lisa und Michael Pascal HENGARTNER, 2020. Comparative efficacy of placebos in short-term antidepressant trials for major depression : a secondary meta-analysis of placebo-controlled trials. BMC Psychiatry. 2020. Bd. 20, Nr. 1, S. 437. DOI 10.1186/s12888-020-02839-y
Holper, Lisa, and Michael Pascal Hengartner. 2020. “Comparative Efficacy of Placebos in Short-Term Antidepressant Trials for Major Depression : A Secondary Meta-Analysis of Placebo-Controlled Trials.” BMC Psychiatry 20 (1): 437. https://doi.org/10.1186/s12888-020-02839-y.
Holper, Lisa, and Michael Pascal Hengartner. “Comparative Efficacy of Placebos in Short-Term Antidepressant Trials for Major Depression : A Secondary Meta-Analysis of Placebo-Controlled Trials.” BMC Psychiatry, vol. 20, no. 1, 2020, p. 437, https://doi.org/10.1186/s12888-020-02839-y.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.